Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Quote. Delayed Toronto Stock Exchange - 01/21 04:00:00 pm
2.04 CAD   -7.27%
01/13OPSENS : 52-109 F2 CEO Certification
PU
01/13OPSENS : 52-109 F2 CFO Certification
PU
01/13Opsens Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OpSens Reports Q4 $1.2 Million Net Loss; Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure

11/23/2021 | 08:09am EST


© MT Newswires 2021
All news about OPSENS INC.
01/13OPSENS : 52-109 F2 CEO Certification
PU
01/13OPSENS : 52-109 F2 CFO Certification
PU
01/13Opsens Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021
CI
01/13OpSens Reports Q1 Loss of $0.02 Per Diluted Share, as Q1 Revenue Misses Forecast
MT
01/13OPSENS BRIEF : Q1 Revs $8.096 Million Vs Forecast 8.53 Million and Last Year 8.34 Million
MT
01/13OPSENS BRIEF : Q1 EPS Basic and Diluted ($0.02) Vs Forecast EPS Normalized ($0.01) As Per ..
MT
01/13OpSens Announces FIRST Quarter fiscal 2022 Financial Results
AQ
01/06Opsens to host first quarter fiscal year 2022 financial results conference call on thur..
AQ
2021OPSENS : Annual Information Form
PU
2021OPSENS : Management information circular - English
PU
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2022 40,3 M 32,0 M 32,0 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 220 M 176 M 175 M
Capi. / Sales 2022 5,47x
Capi. / Sales 2023 2,78x
Nbr of Employees 163
Free-Float 95,2%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,04 CAD
Average target price 4,29 CAD
Spread / Average Target 110%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.-34.19%176
THERMO FISHER SCIENTIFIC-13.03%228 678
DANAHER CORPORATION-14.76%200 403
INTUITIVE SURGICAL, INC.-24.98%96 286
SIEMENS HEALTHINEERS AG-7.72%77 272
EDWARDS LIFESCIENCES CORPORATION-13.05%70 331